FAMRX | RGWFX | FAMRX / RGWFX | |
Total Expense Ratio | 0.65 | 0.43 | 151% |
Annual Report Gross Expense Ratio | 0.65 | 0.43 | 151% |
Fund Existence | 26 years | 13 years | - |
Gain YTD | 13.205 | 13.652 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.94B | 23.6B | 21% |
Annual Yield % from dividends | 1.31 | 0.64 | 205% |
Returns for 1 year | 13.27 | 13.86 | 96% |
Returns for 3 years | 33.33 | 35.31 | 94% |
Returns for 5 years | 51.85 | 43.62 | 119% |
Returns for 10 years | 88.88 | 87.81 | 101% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TADGX | 83.68 | N/A | N/A |
T. Rowe Price Dividend Growth Advisor | |||
WFDSX | 32.67 | N/A | N/A |
Allspring SMID Cap Growth Fund - Cl Inst | |||
ICTEX | 16.82 | N/A | N/A |
ICON Health and Information Tech Instl | |||
GEMUX | 27.40 | N/A | N/A |
Goldman Sachs Emerging Markets Eq R6 | |||
MLNAX | 27.06 | N/A | N/A |
Morgan Stanley Instl Glbl Concntr A |